Dyslipidemia in PCOS

Steroids

Volumn 77, Issue 4, 2012, Pages 295-299

  Wild, Robert A ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Apolipoprotein; Dyslipidemia; Lipid metabolism; PCOS

Indexed keywords

ANDROGEN; APOLIPOPROTEIN A; APOLIPOPROTEIN B; APOLIPOPROTEIN C1; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; BILE ACID SEQUESTRANT; ESTROGEN; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; TRIACYLGLYCEROL;

CARDIOVASCULAR RISK; CONFERENCE PAPER; DIET THERAPY; DYSLIPIDEMIA; ENVIRONMENTAL FACTOR; EXERCISE; HUMAN; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; LIPID METABOLISM; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PROTEIN METABOLISM; WAIST CIRCUMFERENCE;

ANDROGENS; ANIMALS; APOLIPOPROTEINS; DYSLIPIDEMIAS; FEMALE; HUMANS; LIPASE; LIPOPROTEINS, LDL; POLYCYSTIC OVARY SYNDROME;

EID: 84857062605     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2011.12.002     Document Type: Conference Paper

References (22)

1. C.M. DeUgarte, A.A. Bartolucci, and R. Azziz Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment Fertil Steril 83 5 2005 1454 1460 (Pubitemid 40615820)
2. A. Dunaif, K.R. Segal, W. Futterweit, and A. Dobrjansky Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome Diabetes 38 9 1989 1165 1174 (Pubitemid 19250404)
3. R.A. Wild, P.C. Painter, P.B. Coulson, K.B. Carruth, and G.B. Ranney Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome J Clin Endocrinol Metab 61 5 1985 946 951 (Pubitemid 16218495)
4. R.A. Wild, M. Rizzo, S. Clifton, and E. Carmina Dyslipidemia in PCOS: systematic review and meta-analysis Fertil Steril 95 3 2011 1073 1079
5. R.A. Wild, and M.J. Bartholomew The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome Am J Obstet Gynecol 159 2 1988 423 427
6. R.A. Wild, P. Alaupovic, and I.J. Parker Lipid and apolipoprotein abnormalities in hirsute women. I. The association with insulin resistance Am J Obstet Gynecol 166 4 1992 1191 1196
7. S. Huang, J. Qiao, R. Li, L. Wang, and M. Li Can serum apolipoprotein C-I demonstrate metabolic abnormality early in women with polycystic ovary syndrome? Fertil Steril 94 1 2010 205 210
8. S. Yusuf, S. Hawken, and S. Ounpuu Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet 364 9438 2004 937 952 (Pubitemid 39208455)
9. A.D. Sniderman, J. DeGraaf, P. Couture, K. Williams, R.S. Kiss, and G.F. Watts Regulation of plasma LDL: the apoB paradigm Clin Sci (Lond) 118 5 2010 333 339
10. A. Sniderman, K. Williams, and J. DeGraaf Non-HDL C equals apolipoprotein B: except when it does not! Curr Opin Lipidol 21 6 2010 518 524
11. A.D. Sniderman, K. Williams, and J.H. Contois A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk Circ Cardiovasc Qual Outcomes 4 3 2011 337 345
12. H.N. Ginsberg, and W.V. Brown Apolipoprotein CIII: 42 years old and even more interesting Arterioscler Thromb Vasc Biol 31 3 2011 471 473
13. I.R. Pirwany, R. Fleming, I.A. Greer, C.J. Packard, and N. Sattar Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters Clin Endocrinol (Oxf) 54 4 2001 447 453 (Pubitemid 34204180)
14. K. Berneis, M. Rizzo, V. Lazzarini, F. Fruzzetti, and E. Carmina Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome J Clin Endocrinol Metab 92 1 2007 186 189 (Pubitemid 46067529)
15. M. Rizzo, K. Berneis, E. Carmina, and G.B. Rini How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome? Am J Obstet Gynecol 198 1 2008 28 e1-e5
16. O. Valkenburg, R.P. Steegers-Theunissen, and H.P. Smedts A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study J Clin Endocrinol Metab 93 2 2008 470 476 (Pubitemid 351240818)
17. S.M. Bhattacharya Metabolic syndrome in females with polycystic ovary syndrome and International Diabetes Federation criteria J Obstet Gynaecol Res 34 1 2008 62 66 (Pubitemid 351143719)
18. Meyer ML, Malek AM, Wild RA, Korytkowski MT, Talbott EO. Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update, in press.
19. L.B. Tanko, Y.Z. Bagger, G. Qin, P. Alexandersen, P.J. Larsen, and C. Christiansen Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women Circulation 111 15 2005 1883 1890 (Pubitemid 40570207)
20. G.J. Blake, J.D. Otvos, N. Rifai, and P.M. Ridker Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women Circulation 106 15 2002 1930 1937 (Pubitemid 35176297)
21. G. Walldius, I. Jungner, I. Holme, A.H. Aastveit, W. Kolar, and E. Steiner High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study Lancet 358 9298 2001 2026 2033 (Pubitemid 34084825)
22. R.A. Wild, E. Carmina, and E. Diamanti-Kandarakis Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society J Clin Endocrinol Metab 95 5 2010 2038 2049